Market Closed

KNSA
Kiniksa Pharmaceuticals, Ltd.
$ 96.33
0.05%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Kiniksa Pharmaceuticals, Ltd. News

Latest Kiniksa Pharmaceuticals, Ltd. Stock News & KNSA Headlines

AlphaCentric Advisors LLC Acquires New Position in Kiniksa Pharmaceuticals International, plc $KNSA
8 days ago | defenseworld.net
Here's Why Kiniksa Pharmaceuticals International, plc (KNSA) is a Strong Momentum Stock
10 days ago | zacks.com
Kiniksa Pharmaceuticals: 3 Key Takeaways for Long-Term Investors
18 days ago | fool.com
What Kiniksa Pharmaceuticals International (KNSA) Said on Its Q3 Earnings Call
18 days ago | marketbeat.com
Kiniksa Pharmaceuticals International, plc (KNSA) Q3 2026 Earnings Call Transcript
18 days ago | seekingalpha.com
Kiniksa Pharmaceuticals International, plc (KNSA) Q3 Earnings and Revenues Surpass Estimates
19 days ago | zacks.com
Kiniksa Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Portfolio Execution
19 days ago | globenewswire.com
Kiniksa Pharmaceuticals to Report Third Quarter 2026 Financial Results on October 27, 2026
23 days ago | globenewswire.com
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Hits New 52-Week High – Still a Buy?
25 days ago | defenseworld.net
Head-To-Head Survey: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) versus Mirum Pharmaceuticals (NASDAQ:MIRM)
a month ago | defenseworld.net
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

KNSA
Kiniksa Pharmaceuticals, Ltd.
$ 96.33
0.05%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago